[COVID-19 在重症监护室]
Pneumologie (Stuttgart, Germany)
|May 17, 2024
概括
急性呼吸窘迫综合征 (ARDS) 和COVID-19相关的ARDS (C-ARDS) 具有相似的病理生理学,影响血液-空气屏障. 目前的重症监护治疗侧重于器官支持和预防这两种疾病的并发症.
科学领域:
- 重症监护医药重症监护医药重症监护医药重症监护医药
- 肺部病理学 肺部病理学
- 关键的护理关键的护理
背景情况:
- 50多年来,急性呼吸困扰综合征 (ARDS) 和急性呼吸衰竭 (ARF) 已经带来了重大的临床挑战.
- 对于ARDS/ARF的治疗选择主要是支持性,重点是器官功能和预防阳性损害.
- SARS-CoV-2的出现导致了COVID-19相关的ARDS (C-ARDS) 的增加,呈现出与经典ARDS相似的病理生理机制.
研究的目的:
- 总结目前的重症监护室 (ICU) 对急性呼吸衰竭 (ARF) 和ARDS的治疗策略.
- 要突出古典ARDS和C-ARDS在病理生理学和治疗方面的相似之处.
- 在ARDS管理中提供支持性护理和并发症预防的概述.
主要方法:
- 对ARDS和C-ARDS治疗现有文献和临床指南的审查.
- 经典ARDS和C-ARDS之间的病理生理相似性的总结.
- 专注于重症监护病房 (ICU) 管理策略.
主要成果:
- 经典的ARDS和C-ARDS都涉及炎症,导致血液-空气屏障的破坏.
- 这两种疾病的治疗策略都集中在器官功能支持和预防二次损伤上.
- 集中护理干预的目的是减轻严重的肺损伤的影响.
结论:
- 经典ARDS和C-ARDS的病理生理路径基本上是相似的.
- 有效的ARDS和C-ARDS管理依赖于ICU环境中的支持性护理.
- 预防治疗引起的并发症仍然是治疗严重呼吸衰竭患者的关键方面.
相关概念视频
Acute Respiratory Failure-I
202
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
202
Acute Respiratory Failure-II
217
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
217
Acute Respiratory Failure-III
183
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
183
Acute Respiratory Failure-V
135
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
135
Pneumonia III: Complications and Assessment
203
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
203
Acute Respiratory Failure-IV
153
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
153


